These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 36197094)

  • 41. CFTR Protects against Mycobacterium abscessus Infection by Fine-Tuning Host Oxidative Defenses.
    Bernut A; Dupont C; Ogryzko NV; Neyret A; Herrmann JL; Floto RA; Renshaw SA; Kremer L
    Cell Rep; 2019 Feb; 26(7):1828-1840.e4. PubMed ID: 30759393
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study.
    Bryant JM; Grogono DM; Greaves D; Foweraker J; Roddick I; Inns T; Reacher M; Haworth CS; Curran MD; Harris SR; Peacock SJ; Parkhill J; Floto RA
    Lancet; 2013 May; 381(9877):1551-60. PubMed ID: 23541540
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity
    Wu W; He S; Li A; Guo Q; Tan Z; Liu S; Wang X; Zhang Z; Li B; Chu H
    Antimicrob Agents Chemother; 2022 Sep; 66(9):e0060122. PubMed ID: 35969055
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adaptive Immune Response to
    Mauch RM; Jensen PØ; Qvist T; Kolpen M; Moser C; Pressler T; Nolasco da Silva MT; Høiby N;
    Front Cell Infect Microbiol; 2022; 12():858398. PubMed ID: 35548464
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of infection-induced vascular pathologies is protective against persistent rough morphotype Mycobacterium abscessus infection in zebrafish.
    Kam JY; Wright K; Britton WJ; Oehlers SH
    Microb Pathog; 2022 Jun; 167():105590. PubMed ID: 35588967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rifabutin Is Bactericidal against Intracellular and Extracellular Forms of Mycobacterium abscessus.
    Johansen MD; Daher W; Roquet-Banères F; Raynaud C; Alcaraz M; Maurer FP; Kremer L
    Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32816730
    [No Abstract]   [Full Text] [Related]  

  • 47. Reduced Sphingosine in Cystic Fibrosis Increases Susceptibility to
    Schnitker F; Liu Y; Keitsch S; Soddemann M; Verhasselt HL; Kehrmann J; Grassmé H; Kamler M; Gulbins E; Wu Y
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762308
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Promising antibacterial efficacy of arenicin peptides against the emerging opportunistic pathogen Mycobacterium abscessus.
    Casanova M; Maresca M; Poncin I; Point V; Olleik H; Boidin-Wichlacz C; Tasiemski A; Mabrouk K; Cavalier JF; Canaan S
    J Biomed Sci; 2024 Jan; 31(1):18. PubMed ID: 38287360
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
    Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
    Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Mycobacterium tuberculosis NBTI DNA Gyrase Inhibitor Is Active against Mycobacterium abscessus.
    Ganapathy US; Del Río RG; Cacho-Izquierdo M; Ortega F; Lelièvre J; Barros-Aguirre D; Aragaw WW; Zimmerman MD; Lindman M; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0151421. PubMed ID: 34606340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nontuberculous Mycobacterial Infections in Cystic Fibrosis.
    Martiniano SL; Nick JA; Daley CL
    Clin Chest Med; 2016 Mar; 37(1):83-96. PubMed ID: 26857770
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nontuberculous mycobacterial ocular infections--comparing the clinical and microbiological characteristics between Mycobacterium abscessus and Mycobacterium massiliense.
    Chu HS; Chang SC; Shen EP; Hu FR
    PLoS One; 2015; 10(1):e0116236. PubMed ID: 25581038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nontuberculous mycobacteria: the changing epidemiology and treatment challenges in cystic fibrosis.
    Leung JM; Olivier KN
    Curr Opin Pulm Med; 2013 Nov; 19(6):662-9. PubMed ID: 24048085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dectin-1-Independent Macrophage Phagocytosis of
    Ochoa AE; Congel JH; Corley JM; Janssen WJ; Nick JA; Malcolm KC; Hisert KB
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446240
    [No Abstract]   [Full Text] [Related]  

  • 55.
    Pang Y; Zheng H; Tan Y; Song Y; Zhao Y
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28242674
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular Epidemiological Characteristics of Mycobacterium abscessus Complex Derived from Non-Cystic Fibrosis Patients in Japan and Taiwan.
    Yoshida M; Chien JY; Morimoto K; Kinjo T; Aono A; Murase Y; Fujiwara K; Morishige Y; Nagano H; Jou R; Hasegawa N; Ato M; Hoshino Y; Hsueh PR; Mitarai S
    Microbiol Spectr; 2022 Jun; 10(3):e0057122. PubMed ID: 35446117
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-Tuberculous Mycobacteria multispecies biofilms in cystic fibrosis: development of an in vitro Mycobacterium abscessus and Pseudomonas aeruginosa dual species biofilm model.
    Rodríguez-Sevilla G; García-Coca M; Romera-García D; Aguilera-Correa JJ; Mahíllo-Fernández I; Esteban J; Pérez-Jorge C
    Int J Med Microbiol; 2018 Apr; 308(3):413-423. PubMed ID: 29555180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case-control study.
    Verregghen M; Heijerman HG; Reijers M; van Ingen J; van der Ent CK
    J Cyst Fibros; 2012 Jul; 11(4):340-3. PubMed ID: 22342403
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural Products Lysobactin and Sorangicin A Show
    Sullivan JR; Yao J; Courtine C; Lupien A; Herrmann J; Müller R; Behr MA
    Microbiol Spectr; 2022 Dec; 10(6):e0267222. PubMed ID: 36342177
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran.
    Heidarieh P; Mirsaeidi M; Hashemzadeh M; Feizabadi MM; Bostanabad SZ; Nobar MG; Hashemi Shahraki A
    Microb Drug Resist; 2016 Mar; 22(2):172-8. PubMed ID: 26468990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.